LTUS.US Lotus Pharmaceuticals Inc

Financial Services Pharmaceuticals USA Stocks
0.0031 USD
Close of Nov 16, 2026
0.0018 0.0062
Market cap
USD 8.20M
P/E
-
P/B
0.01x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is LTUS.US undervalued?

Graham number

The Graham number of Lotus Pharmaceuticals Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Lotus Pharmaceuticals Inc fundamental analysis

No fundamental analysis for Lotus Pharmaceuticals Inc yet.

Lotus Pharmaceuticals Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Lotus Pharmaceuticals Inc

Lotus Pharmaceuticals, Inc. operates as a high-conviction pharmaceutical and healthcare investment and industry integration company. The company focuses on building a asset portfolio across the global pharmaceutical and healthcare value chain through global strategic investments, mergers and acquisitions, and industry consolidation. It seeks opportunities across pharmaceuticals and biologics, biopharmaceutical services (CRO/CDMO), oncology pharmaceuticals, medical institutio…

Full company profile